Immunogenicity and Safety of an Adjuvanted Inactivated Subunit Influenza Vaccine to Those of a Non-adjuvanted Inactivated Subunit Influenza Vaccine, When Administered to Adults Affected by Chronic Diseases

PHASE3CompletedINTERVENTIONAL

Enrollment

361

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

December 31, 2006

Study Completion Date

May 31, 2007

Conditions

Influenza Disease

Interventions

BIOLOGICAL

Adjuvanted influenza vaccine

Trial Locations (1)

Azienda ULSS 13 di Mirano, Mira, Via Nazionale 48